Magnetic resonance imaging for screening, diagnosis, and eligibility for breast-conserving surgery: promises and pitfalls

Surgical Oncology Clinics of North America

Volumn 19, Issue 3, 2010, Pages 475-492

  Morrow, Monica ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Breast conserving therapy; Local recurrence; Magnetic resonance imaging; Occult cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

AXILLARY LYMPH NODE; BREAST BIOPSY; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOMAMMOGRAPHY; FALSE POSITIVE RESULT; FAMILY HISTORY; GENE MUTATION; HISTOPATHOLOGY; HUMAN; INDIVIDUALIZATION; INTERMETHOD COMPARISON; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; LYMPHADENOPATHY; MAMMOGRAPHY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; PATIENT CARE; PATIENT SELECTION; PREDICTION; RECURRENCE RISK; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR LOCALIZATION; TUMOR VOLUME; BREAST TUMOR; FEMALE; ORGANIZATION AND MANAGEMENT; SEGMENTAL MASTECTOMY;

BREAST NEOPLASMS; ELIGIBILITY DETERMINATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MASTECTOMY, SEGMENTAL;

EID: 77954157134     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2010.03.003     Document Type: Review

References (81)

1. Berry D.A., Cronin K.A., Plevritis S.K., et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005, 353(17):1784-1792.
2. Poggi M.M., Danforth D.N., Sciuto L.C., et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 2003, 98(4):697-702.
3. van Dongen J.A., Voogd A.C., Fentiman I.S., et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000, 92(14):1143-1150.
4. Kaufmann M., Morrow M., von Minckwitz G., et al. Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel. Cancer 2010, 116(5):1184-1191.
5. Morrow M., Harris J.R. Practice guideline for breast conservation therapy in the management of invasive breast cancer. J Am Coll Surg 2007, 205:362-376.
6. Ernst M.F., Voogd A.C., Coebergh J.W., et al. Using loco-regional recurrence as an indicator of the quality of breast cancer treatment. Eur J Cancer 2004, 40(4):487-493.
7. Pass H., Vicini F.A., Kestin L.L., et al. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution. Cancer 2004, 101(4):713-720.
8. Otto S.J., Fracheboud J., Looman C.W., et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 2003, 361(9367):1411-1417.
9. Pisano E.D., Gatsonis C., Hendrick E., et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 2005, 353(17):1773-1783.
10. Kerlikowske K. Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit. J Natl Cancer Inst Monogr 1997, 22:79-86.
11. Brekelmans C.T., Seynaeve C., Bartels C.C., et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 2001, 19(4):924-930.
12. Kuhl C.K., Schrading S., Leutner C.C., et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005, 23(33):8469-8476.
13. Lakhani S.R., Jacquemier J., Sloane J.P., et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 1998, 90(15):1138-1145.
14. Sardanelli F., Giuseppetti G.M., Panizza P., et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol 2004, 183(4):1149-1157.
15. Warner E., Messersmith H., Causer P., et al. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 2008, 148(9):671-679.
16. Warner E., Plewes D.B., Hill K.A., et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004, 292(11):1317-1325.
17. Kriege M., Brekelmans C.T., Boetes C., et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004, 351(5):427-437.
18. Leach M.O., Boggis C.R., Dixon A.K., et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005, 365(9473):1769-1778.
19. Hagen A.I., Kvistad K.A., Maehle L., et al. Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series. Breast 2007, 16(4):367-374.
20. Kuhl C.K., Schrading S., Bieling H.B., et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 2007, 370(9586):485-492.
21. Port E.R., Park A., Borgen P.I., et al. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Ann Surg Oncol 2007, 14(3):1051-1057.
22. Saslow D., Boetes C., Burke W., et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007, 57(2):75-89.
23. Morrow M., Bucci C., Rademaker A. Medical contraindications are not a major factor in the underutilization of breast conserving therapy. J Am Coll Surg 1998, 186(3):269-274.
24. Holland R., Veling S.H., Mravunac M., et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985, 56(5):979-990.
25. Lagios M.D. Multicentricity of breast carcinoma demonstrated by routine correlated serial subgross and radiographic examination. Cancer 1977, 40(4):1726-1734.
26. Schwartz G.F., Patchesfsky A.S., Feig S.A., et al. Multicentricity of non-palpable breast cancer. Cancer 1980, 45(12):2913-2916.
27. Anderson S.J., Wapnir I., Dignam J.J., et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol 2009, 27(15):2466-2473.
28. Wapnir I.L., Anderson S.J., Mamounas E.P., et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 2006, 24(13):2028-2037.
29. Houssami N., Ciatto S., Macaskill P., et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008, 26(19):3248-3258.
30. Mann R.M., Hoogeveen Y.L., Blickman J.G., et al. MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res Treat 2008, 107(1):1-14.
31. Berg W.A., Gutierrez L., NessAiver M.S., et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004, 233(3):830-849.
32. Liberman L., Morris E.A., Dershaw D.D., et al. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol 2003, 180(4):901-910.
33. Katipamula R., Degnim A.C., Hoskin T., et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 2009, 27(25):4082-4088.
34. Morrow M., Schmidt R., Hassett C. Patient selection for breast conservation therapy with magnification mammography. Surgery 1995, 118(4):621-626.
35. Morrow M., Jagsi R., Alderman A.K., et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA 2009, 302(14):1551-1556.
36. Bleicher R.J., Ciocca R.M., Egleston B.L., et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg 2009, 209(2):180-187. [quiz: 294-5].
37. Pengel K.E., Loo C.E., Teertstra H.J., et al. The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study. Breast Cancer Res Treat 2009, 116(1):161-169.
38. Drew P.J., Harvey I., Hanby A., et al. The UK NIHR multi-centre randomised COMICE trial of MRI planning for breast conserving treatment for breast cancer. Cancer Res 2009, 69(Suppl 2). [abstract 51].
39. Schiller D.E., Le L.W., Cho B.C., et al. Factors associated with negative margins of lumpectomy specimen: potential use in selecting patients for intraoperative radiotherapy. Ann Surg Oncol 2008, 15(3):833-842.
40. Hwang N., Schiller D.E., Crystal P., et al. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy. Ann Surg Oncol 2009, 16(11):3000-3009.
41. Mann R.M., Loo C.E., Wobbes T., et al. The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat 2010, 119(2):415-422.
42. Morrow M., Keeney K., Scholtens D., et al. Selecting patients for breast-conserving therapy: the importance of lobular histology. Cancer 2006, 106(12):2563-2568.
43. Schouten van der Velden A.P., Boetes C., Bult P., et al. Magnetic resonance imaging in size assessment of invasive breast carcinoma with an extensive intraductal component. BMC Med Imaging 2009, 9:5.
44. Van Goethem M., Schelfout K., Kersschot E., et al. MR mammography is useful in the preoperative locoregional staging of breast carcinomas with extensive intraductal component. Eur J Radiol 2007, 62(2):273-282.
45. Wasif N., Garreau J., Terando A., et al. MRI versus ultrasonography and mammography for preoperative assessment of breast cancer. Am Surg 2009, 75(10):970-975.
46. Pettit K., Swatske M.E., Gao F., et al. The impact of breast MRI on surgical decision-making: are patients at risk for mastectomy?. J Surg Oncol 2009, 100(7):553-558.
47. King T.A., Sakr R., Gurevich I., et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. Cancer Res 2009, 69(Suppl 24):494s. [#438].
48. Fourquet A., Kirova Y.M., Campana F. Occult primary cancer with axillary metastases. Diseases of the breast 2010, 817-821. Lippincott Williams & Wilkins, Philadelphia. 4th edition. J.R. Harris, M.E. Lippman, M. Morrow (Eds.).
49. Ellerbroek N., Holmes F., Singletary E., et al. Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin. Cancer 1990, 66(7):1461-1467.
50. Kemeny M.M., Rivera D.E., Terz J.J., et al. Occult primary adenocarcinoma with axillary metastases. Am J Surg 1986, 152(1):43-47.
51. Buchanan C.L., Morris E.A., Dorn P.L., et al. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol 2005, 12(12):1045-1053.
52. McMahon K., Medoro L., Kennedy D. Breast magnetic resonance imaging: an essential role in malignant axillary lymphadenopathy of unknown origin. Australas Radiol 2005, 49(5):382-389.
53. Olson J.A., Morris E.A., Van Zee K.J., et al. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol 2000, 7(6):411-415.
54. Orel S.G., Weinstein S.P., Schnall M.D., et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 1999, 212(2):543-549.
55. Henry-Tillman R.S., Harms S.E., Westbrook K.C., et al. Role of breast magnetic resonance imaging in determining breast as a source of unknown metastatic lymphadenopathy. Am J Surg 1999, 178(6):496-500.
56. Morris E.A., Schwartz L.H., Dershaw D.D., et al. MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 1997, 205(2):437-440.
57. Ko E.Y., Han B.K., Shin J.H., et al. Breast MRI for evaluating patients with metastatic axillary lymph node and initially negative mammography and sonography. Korean J Radiol 2007, 8(5):382-389.
58. de Bresser J., de Vos B., van der Ent F., et al. Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review. Eur J Surg Oncol 2010, 36(2):114-119.
59. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366(9503):2087-2106.
60. Fischer U., Zachariae O., Baum F., et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 2004, 14(10):1725-1731.
61. Solin L.J., Orel S.G., Hwang W.T., et al. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 2008, 26(3):386-391.
62. Nguyen P.L., Taghian A.G., Katz M.S., et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 2008, 26(14):2373-2378.
63. Kyndi M., Sorensen F.B., Knudsen H., et al. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol 2008, 26(9):1419-1426.
64. Gao X., Fisher S.G., Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 2003, 56(4):1038-1045.
65. Lehman C.D., Gatsonis C., Kuhl C.K., et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007, 356(13):1295-1303.
66. Cody H.S. Routine contralateral breast biopsy: helpful or irrelevant? Experience in 871 patients, 1979-1993. Ann Surg 1997, 225(4):370-376.
67. Pressman P.I. Selective biopsy of the opposite breast. Cancer 1986, 57(3):577-580.
68. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 365(9472):1687-1717.
69. Brennan M.E., Houssami N., Lord S., et al. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management. J Clin Oncol 2009, 27(33):5640-5649.
70. Sorbero M.E., Dick A.W., Beckjord E.B., et al. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol 2009, 16(6):1597-1605.
71. van Tienhoven G., Voogd A.C., Peterse J.L., et al. Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer 1999, 35(1):32-38.
72. Voogd A.C., van Tienhoven G., Peterse H.L., et al. Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch Study Group on Local Recurrence after Breast Conservation (BORST). Cancer 1999, 85(2):437-446.
73. Gage I., Schnitt S.J., Recht A., et al. Skin recurrences after breast-conserving therapy for early-stage breast cancer. J Clin Oncol 1998, 16(2):480-486.
74. Fisher E.R., Anderson S., Redmond C., et al. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06. Semin Surg Oncol 1992, 8(3):161-166.
75. Veronesi U., Marubini E., Del Vecchio M., et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 1995, 87(1):19-27.
76. Galper S., Blood E., Gelman R., et al. Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2005, 61(2):348-357.
77. Kurtz J.M., Jacquemier J., Amalric R., et al. Is breast conservation after local recurrence feasible?. Eur J Cancer 1991, 27(3):240-244.
78. Salvadori B., Veronesi U. Conservative methods for breast cancer of small size: the experience of the National Cancer Institute, Milan (1973-1998). Breast 1999, 8(6):311-314.
79. Millar E.K., Graham P.H., O'Toole S.A., et al. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. J Clin Oncol 2009, 27(28):4701-4708.
80. Fortin A., Larochelle M., Laverdiere J., et al. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol 1999, 17(1):101-109.
81. Fourquet A., Campana F., Zafrani B., et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys 1989, 17(4):719-725.